Wohl, D A <br/><br/>
Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.  [electronic resource] 

 -  HIV clinical trials   
 - 143-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-4336 
<br/><br/><label>Standard No.: </label>10.1310/hct1003-143  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Opportunistic Infections--drug therapy<br/>Acquired Immunodeficiency Syndrome--drug therapy<br/>Adult<br/>Antiretroviral Therapy, Highly Active<br/>Antiviral Agents--administration & dosage<br/>CD4 Lymphocyte Count<br/>Cytomegalovirus--genetics<br/>Cytomegalovirus Infections--drug therapy<br/>Double-Blind Method<br/>Ganciclovir--administration & dosage<br/>HIV Infections--complications<br/>Humans<br/>Middle Aged<br/>Polymerase Chain Reaction<br/>Proportional Hazards Models<br/>Valganciclovir<br/>Viremia--drug therapy